Presidential Coordinator for the Ghana Pharmaceutical Hub, Dr Bernice Makafui Brempong has thrown his support behind the government’s new policy aimed at positioning Ghana as a major pharmaceutical manufacturing hub in Africa, describing the initiative as a significant step towards industrial growth and economic transformation.
The policy, launched by the Minister for Trade, Agribusiness and Industry, Elizabeth Ofosu-Adjare, seeks to reduce Ghana’s dependence on imported medicines while strengthening local pharmaceutical production.
The initiative is expected to attract investment into the pharmaceutical sector, expand domestic manufacturing capacity and create employment opportunities, particularly for pharmacists and other professionals within the pharmaceutical value chain.
Speaking on the policy, Dr Brempong said the Ghana Pharmaceutical Hub, a presidential legacy initiative under the New Economy Programme, would provide an important platform for translating the government’s industrial transformation agenda into tangible economic opportunities.
She noted that the initiative had the potential to stimulate investment, promote local industries and position Ghana as a competitive destination for pharmaceutical manufacturing.
With the policy now approved and officially launched, attention is expected to shift towards its implementation, particularly the mobilisation of private-sector investment and the development of the necessary infrastructure to support large-scale pharmaceutical production.
The Central Region is expected to host the second phase of the Pharmaceutical Hub project, further extending the initiative beyond its initial development phase.
Dr Brempong also highlighted the importance of private-sector participation in ensuring the successful implementation of the policy, noting that sustained collaboration between government and industry players would be critical to achieving its objectives.
The Ghana Pharmaceutical Hub forms part of the government’s broader strategy to strengthen local industries, create jobs, reduce import dependency and build a more resilient economy.
If successfully implemented, the initiative could mark a major turning point for Ghana’s pharmaceutical industry, while opening up new opportunities for investment, innovation and employment.
About the Author
